Skip to main content
. 2026 Mar 5;14(3):97. doi: 10.3390/diseases14030097
dCCA distal cholangiocarcinoma
OS overall survival
CINS Cholangiocarcinoma Inflammation–Nutrition Score
CA19-9 carbohydrate antigen 19-9
TNM tumor–node–metastasis
DFS disease-free survival
IL-6 interleukin-6
TNF-α tumor necrosis factor-alpha
CAR C-reactive protein-to-albumin ratio
NLR neutrophil-to-lymphocyte ratio
PNI prognostic nutritional index
PLR platelet-to-lymphocyte ratio
AJCC American Joint Committee on Cancer
ERCP endoscopic retrograde cholangiopancreatography
PTBD percutaneous transhepatic biliary drainage
IQR interquartile range
R0 no residual tumor
HR hazard ratio
CI confidence interval
VIF variance inflation factor
AUC area under the curve
ROC receiver operating characteristic
DCA decision curve analysis
NRI net reclassification improvement
IDI integrated discrimination improvement
PDGF platelet-derived growth factor
STAT3 signal transducer and activator of transcription 3
HCC hepatocellular carcinoma
PIPL Personal Information Protection Law
ctDNA circulating tumor DNA